Scott Gottlieb, M.D., American Enterprise Institute, and Jeff Allen, Friends of Cancer Research executive director, discuss the FDA’s drug approval process and the need in some cases to allow access to experimental therapies.
Scott Gottlieb, M.D., American Enterprise Institute, and Jeff Allen, Friends of Cancer Research executive director, discuss the FDA’s drug approval process and the need in some cases to allow access to experimental therapies.
